文献速递血栓与止血

原发免疫性血小板减少症患者纤维蛋白溶解功能受损

Fibrinolysis is impaired in patients with primary immune thrombocytopenia.
PubMed 文献 · J Thromb Haemost · 2024-08-28

研究纳入86例成人原发免疫性血小板减少症(ITP)患者和78名健康对照,采用浊度法血凝块形成与溶解试验及荧光法纤溶酶生成(PG)试验,发现ITP患者血凝块溶解时间(CLT)延长、纤溶酶生成延迟,PAI-1升高而tPA降低,tPA-PAI-1复合物水平与CLT正相关,且未来发生血栓的患者该复合物水平更高。

要点

  • ITP患者血凝块溶解时间(CLT)中位数28.0分钟,较健康对照17.3分钟延长。
  • ITP患者PAI-1升高、tPA抗原及活性降低,提示纤溶功能低下。
  • tPA-PAI-1复合物水平与CLT正相关,未来发生血栓者该复合物更高。

核心结论

  • ITP患者CLT延长和纤溶酶生成延迟提示纤溶功能低下,表现为PAI-1升高和tPA降低。
  • 纤溶潜力与出血表型无关联,但tPA-PAI-1复合物水平升高与CLT延长相关,且在随访期间发生血栓的患者中升高。

研究设计与样本

  • 研究纳入86例成人原发ITP患者和78名健康对照(HCs),进行浊度法血凝块形成与溶解试验及荧光法纤溶酶生成(PG)试验。
  • 检测PAI-1、tPA、tPA-PAI-1复合物、α2-抗纤溶酶、凝血酶激活的纤溶抑制物及D-二聚体水平。

主要发现

  • ITP患者较健康对照血凝块形成延迟、血凝块密度增加、CLT延长,CLT中位数(IQR)为28.0(13.7-34.7)分钟 vs 17.3(12.0-28.0)分钟。
  • PG试验中仅滞后时间延长。
  • ITP患者较对照PAI-1升高(1.2 [0.8-2.6] vs 1.1 [0.6-2.1] U/mL),tPA抗原降低(2.6 [1.1-4.4] vs 3.7 [3.2-4.7] ng/mL),tPA活性≤0 U/mL者比例升高(26% vs 7%)。
  • 多元线性回归分析中tPA-PAI-1复合物水平与CLT正相关(β=0.241;P=.019),PG参数与CLT无关联。
  • 随访期间发生血栓的6例患者tPA-PAI-1复合物水平较高。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patients with primary immune thrombocytopenia (ITP) have an increased risk of thrombosis, which may be due to altered fibrinolysis. OBJECTIVES: To elucidate the clinical impact of delayed fibrinolysis in ITP patients. METHODS: A turbidimetric clot formation and lysis assay and a fluorometric plasmin generation (PG) assay were performed, and levels of plasminogen activator inhibitor-1 (PAI-1), tissue plasminogen activator (tPA), tPA-PAI-1 complexes, α2-antiplasmin, thrombin activatable fibrinolysis inhibitor, and D-dimer were assessed in 86 adult primary ITP patients and 78 healthy controls (HCs). RESULTS: ITP patients showed significantly delayed clot formation, increased clot density, and prolonged clot lysis time (CLT) compared with HCs, with a median (IQR) CLT of 28.0 (13.7-34.7) minutes in patients and 17.3 (12.0-28.0) minutes in HCs, while in the PG assay, only the lag time was prolonged. In ITP patients compared with controls, PAI-1 was higher (1.2 [0.8-2.6] vs 1.1 [0.6-2.1] U/mL) and tPA antigen and activity were lower (tPA antigen: 2.6 [1.1-4.4] vs 3.7 [3.2-4.7] ng/mL; tPA activity ≤ 0 U/mL: 26% vs 7%). TPA-PAI-1 complex levels were positively associated with CLT in multiple linear regression analysis (β = 0.241; P = .019), whereas PG parameters were not associated with CLT. Six patients who developed thrombosis during follow-up had higher levels of tPA-PAI-1 complexes. CONCLUSION: Prolonged CLT and delayed onset of PG may indicate a hypofibrinolytic tendency in ITP patients, as also indicated by high PAI-1 and low tPA levels. No association was found between fibrinolytic potential and the bleeding phenotype, whereas higher tPA-PAI-1 complex levels were associated with prolonged CLT and increased in patients with future thrombosis.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Schramm T, Rast J, Mehic D, et al. Fibrinolysis is impaired in patients with primary immune thrombocytopenia. J Thromb Haemost. 2024. PMID: 39214313. doi:10.1016/j.jtha.2024.07.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。